These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 18199113)

  • 1. Meta-analysis of mycophenolate mofetil in IgA nephropathy.
    Navaneethan SD; Viswanathan G; Strippoli GF
    Nephrology (Carlton); 2008 Feb; 13(1):90. PubMed ID: 18199113
    [No Abstract]   [Full Text] [Related]  

  • 2. Mycophenolate mofetil in IgA nephropathy.
    Sepe V; Rossi N; Adamo G; Dal Canton A
    Kidney Int; 2004 Oct; 66(4):1713; author reply 1713-4. PubMed ID: 15458475
    [No Abstract]   [Full Text] [Related]  

  • 3. Mycophenolate mofetil for systemic vasculitis and IgA nephropathy.
    Nowack R; Birck R; van der Woude FJ
    Lancet; 1997 Mar; 349(9054):774. PubMed ID: 9074580
    [No Abstract]   [Full Text] [Related]  

  • 4. Mycophenolate mofetil in primary glomerulopathies.
    Sepe V; Libetta C; Giuliano MG; Adamo G; Dal Canton A
    Kidney Int; 2008 Jan; 73(2):154-62. PubMed ID: 17989649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mycophenolate mofetil treatment for IgA nephropathy: a meta-analysis.
    Xu G; Tu W; Jiang D; Xu C
    Am J Nephrol; 2009; 29(5):362-7. PubMed ID: 18974636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapy of IgA nephropathy with mycophenolate mofetil--report of 3 cases.
    Bergner R; Hoffmann M; Brass H; Uppenkamp M
    Clin Nephrol; 2004 Mar; 61(3):207-12. PubMed ID: 15077872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mycophenolate mofetil treatment of crescentic Henoch-Schönlein nephritis with IgA depositions.
    Dede F; Onec B; Ayli D; Gonul II; Onec K
    Scand J Urol Nephrol; 2008; 42(2):178-80. PubMed ID: 17853044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics and pharmacodynamics of mycophenolic acid after enteric-coated mycophenolate versus mycophenolate mofetil in patients with progressive IgA nephritis.
    Czock D; Rasche FM; Carius A; Glander P; Budde K; Bauer S; Keller F; von Müller L
    J Clin Pharmacol; 2007 Jul; 47(7):850-9. PubMed ID: 17526858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of mycophenolate mofetil treatment in IgA nephropathy: a systematic review.
    Chen Y; Li Y; Yang S; Li Y; Liang M
    BMC Nephrol; 2014 Dec; 15():193. PubMed ID: 25475967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mycophenolate Mofetil: A Possible Alternative Treatment for IgA Nephropathy.
    Baraldi O; Comai G; Cuna V; Cappuccilli M; Serra C; Ronco C; La Manna G
    Contrib Nephrol; 2017; 190():108-116. PubMed ID: 28535523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of mycophenolate mofetil in the treatment for IgA nephropathy: a meta-analysis of randomized controlled trials.
    Peng XJ; Zheng WM; Fu R; Huang YH; Deng MH; Tao SS; Wang TJ; Zhu C
    Clin Exp Nephrol; 2021 Jul; 25(7):788-801. PubMed ID: 33710500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mycophenolate mofetil in the treatment of IgA nephropathy: a systematic review.
    Tan CH; Loh PT; Yang WS; Chan CM
    Singapore Med J; 2008 Oct; 49(10):780-5. PubMed ID: 18946610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. One-year angiotensin-converting enzyme inhibition plus mycophenolate mofetil immunosuppression in the course of early IgA nephropathy: a multicenter, randomised, controlled study.
    Dal Canton A; Amore A; Barbano G; Coppo R; Emma F; Grandaliano G; Klersy C; Perfumo F; Rizzoni G; Schena FP; Sepe V;
    J Nephrol; 2005; 18(2):136-40. PubMed ID: 15944996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrent IgA nephropathy after renal transplantation despite immunosuppressive regimens with mycophenolate mofetil.
    Chandrakantan A; Ratanapanichkich P; Said M; Barker CV; Julian BA
    Nephrol Dial Transplant; 2005 Jun; 20(6):1214-21. PubMed ID: 15797890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Early treatment of IgA nephritis is indicated by prognostic factors].
    Barth C
    Dtsch Med Wochenschr; 2000 Aug; 125(34-35):1009. PubMed ID: 11004913
    [No Abstract]   [Full Text] [Related]  

  • 16. Efficacy and safety of mycophenolate mofetil in patients with IgA nephropathy: an update meta-analysis.
    Du B; Jia Y; Zhou W; Min X; Miao L; Cui W
    BMC Nephrol; 2017 Jul; 18(1):245. PubMed ID: 28724421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mycophenolate mofetil in nonlupus glomerulonephropathy.
    Karim MY; Abbs IC
    Lupus; 2005; 14 Suppl 1():s39-41. PubMed ID: 15803930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of immunoglobulin A nephropathy.
    Schiele J; Nowack R; Julian BA; van der Woude FJ
    Ann Med Interne (Paris); 1999 Feb; 150(2):127-36. PubMed ID: 10392261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Mycophenolate mofetil in high risk IgA glomerulonephritis].
    Frutos MA; López V; Alférez MJ; Aranda P
    Nefrologia; 2005; 25(4):387-92. PubMed ID: 16231504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mycophenolate mofetil monotherapy in patients who have had kidney transplants.
    Land W
    Transplantation; 2003 Jun; 75(12):2159. PubMed ID: 12829933
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.